Cambodian PM Hun Sen seeks India's assistance for Covid-19 vaccine
The Cambodian Prime Minister Hun Sen on Monday requested the Indian government to provide the Covid-19 vaccine during his meeting with the new Indian ambassador to Cambodia Devyani Uttamkhobragade, reported The Phnom Penh Post. India produced its own vaccine Covishield and Covaxin that were administered at various medical centres all across India on Saturday.
💡 newsR Knowledge: Other News Mentions
Cambodia launches COVID-19 vaccine programme
Credit: Reuters Studio Duration: 01:05Published
Cambodian beer yoga helps ease lockdown stress
Credit: Reuters Studio Duration: 01:37Published
Cambodia resumes mass trial of government opponents
Credit: Al Jazeera STUDIO Duration: 02:09Published
Sam Rainsy interview on Cambodia's mass opposition trial
Credit: Al Jazeera STUDIO Duration: 05:06Published
Mumbai: 100-yr-old woman vaccinated on her birthday, officials cut cake | Covid
Credit: HT Digital Content Duration: 01:48Published
‘Covid vaccination done for free at govt hospitals in India’: PM Modi
Credit: HT Digital Content Duration: 02:15Published
COVID-19: Centenarian vaccinated with Covishield at Delhi hospitalThe beneficiary was given the Serum Institute of India's (SII) 'Covishield' vaccine which did not cause him any side effect.
Covid vaccine explained: Covishield? Covaxin? Do's and Don'ts | Oneindia News
Credit: Oneindia Duration: 03:13Published
CM Pramod Sawant administers 1st dose of Covishield vaccine
Credit: ANI Duration: 02:18Published
Mexico experts recommend approving Indian vaccineA technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company..
Govt sees Covaxin efficacy as validation of its scientific processThe phase 3 results of Covaxin released on Wednesday showing 81% efficacy is seen by the government as a major validation of the scientific process and..
Covaxin has 81% interim vaccine efficacy - here's what it meansThe trials for the third phase of the vaccine involved 25,800 subjects and it was the largest ever conducted in India.
You Might Like
Related videos from verified sources
Related news from verified sources